在急性病内科患者中，使用直接口服抗凝剂进行静脉血栓栓塞症的延长预防的时机到了吗？ - Suppr

Suppr

超能文献

Has time come for the use of direct oral anticoagulants in the extended prophylaxis of venous thromboembolism in acutely ill medical patients?

作者信息

Piovella Franco, Iosub Diana Irina

机构信息

Thrombosis Unit, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy.

Thrombosis Unit, Ospedale A. Manzoni, Lecco, Italy.

出版信息

Intern Emerg Med. 2018 Oct;13(7):993-995. doi: 10.1007/s11739-018-1953-4. Epub 2018 Sep 27.

DOI:10.1007/s11739-018-1953-4

PMID:30259340

Abstract

摘要

相似文献

Has time come for the use of direct oral anticoagulants in the extended prophylaxis of venous thromboembolism in acutely ill medical patients?

Intern Emerg Med. 2018 Oct;13(7):993-995. doi: 10.1007/s11739-018-1953-4. Epub 2018 Sep 27.

Extended thromboprophylaxis in the acutely ill medical patient after hospitalization - a paradigm shift in post-discharge thromboprophylaxis.

Hosp Pract (1995). 2018 Feb;46(1):5-15. doi: 10.1080/21548331.2018.1410053. Epub 2017 Nov 30.

Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism.

Chest. 2007 Sep;132(3):936-45. doi: 10.1378/chest.06-2993. Epub 2007 Jun 15.

Betrixaban for first-line venous thromboembolism prevention in acute medically ill patients with risk factors for venous thromboembolism.

Expert Rev Cardiovasc Ther. 2018 Nov;16(11):845-855. doi: 10.1080/14779072.2018.1534068. Epub 2018 Oct 15.

Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study.

J Thromb Thrombolysis. 2006 Aug;22(1):31-8. doi: 10.1007/s11239-006-7732-5.

Death Associated with Inadequate Reassessment of Venous Thromboembolism Prophylaxis at and after Hospital Discharge.

Alta RN. 2015 Fall;71(3):26-8.

Pulmonary Venous Thromboembolism in an Acutely Ill Medical Patient Receiving Rivaroxaban.

J Coll Physicians Surg Pak. 2017 Sep;27(9):S129-S130.

Risk assessment and prophylaxis of venous thromboembolism in acutely and/or critically ill patients.

Haemostasis. 2000;30 Suppl 2:77-81; discussion 63. doi: 10.1159/000054168.

Do medical patients need to receive pharmacologic prophylaxis for the prevention of venous thromboembolism?

Intern Emerg Med. 2012 Oct;7 Suppl 3:S189-92. doi: 10.1007/s11739-012-0800-2.

Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.

Thromb Res. 2007;119(2):145-55. doi: 10.1016/j.thromres.2006.01.011. Epub 2006 Mar 3.

引用本文的文献

A focus on direct oral anticoagulants: "old" and possible new indications and efforts for a better clinical management.

Intern Emerg Med. 2018 Oct;13(7):985-988. doi: 10.1007/s11739-018-1954-3. Epub 2018 Sep 21.

本文引用的文献

Has time come for the use of direct oral anticoagulants in the extended prophylaxis of venous thromboembolism in acutely ill medical patients? No.

Intern Emerg Med. 2018 Oct;13(7):1015-1018. doi: 10.1007/s11739-018-1843-9. Epub 2018 Mar 28.

Has time come for the use of direct oral anticoagulants in the extended prophylaxis of venous thromboembolism in acutely ill medical patients? Yes.

Intern Emerg Med. 2018 Oct;13(7):1009-1013. doi: 10.1007/s11739-017-1723-8. Epub 2017 Aug 14.

Thromboprophylaxis with enoxaparin and direct oral anticoagulants in major orthopedic surgery and acutely ill medical patients: a meta-analysis.

Intern Emerg Med. 2017 Dec;12(8):1291-1305. doi: 10.1007/s11739-017-1714-9. Epub 2017 Jul 29.

Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban).

Circulation. 2017 Feb 14;135(7):648-655. doi: 10.1161/CIRCULATIONAHA.116.025427. Epub 2016 Nov 14.

Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients.

N Engl J Med. 2016 Aug 11;375(6):534-44. doi: 10.1056/NEJMoa1601747. Epub 2016 May 27.

The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.

Thromb Haemost. 2016 Jun 2;115(6):1240-8. doi: 10.1160/TH15-09-0756. Epub 2016 Feb 4.

Recognition of biomarker identified high-risk patients in the acute medically ill venous thromboembolism prevention with extended duration betrixaban study resulting in a protocol amendment.

Am Heart J. 2015 Jan;169(1):186-7. doi: 10.1016/j.ahj.2014.09.004. Epub 2014 Sep 19.

D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial.

J Thromb Haemost. 2014 Apr;12(4):479-87. doi: 10.1111/jth.12515.

Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population.

Thromb Res. 2013 Nov;132(5):520-6. doi: 10.1016/j.thromres.2013.08.013. Epub 2013 Aug 28.

Venous thromboembolism in elderly high-risk medical patients: time course of events and influence of risk factors.

Clin Appl Thromb Hemost. 2013 Jul-Aug;19(4):357-62. doi: 10.1177/1076029613481105. Epub 2013 Apr 22.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验